# The Safety, Feasibility and Oncological Outcomes of Laparoscopic Completion Total Gastrectomy for Remnant Gastric Cancer

> **NCT02792881** · NA · UNKNOWN · sponsor: **Fujian Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Remnant Gastric Cancer

## Interventions

- **PROCEDURE:** Laparoscopic completion total gastrectomy with D2 lymphadenectomy

## Key facts

- **NCT ID:** NCT02792881
- **Lead sponsor:** Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2020-06
- **Final completion:** 2023-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792881, "The Safety, Feasibility and Oncological Outcomes of Laparoscopic Completion Total Gastrectomy for Remnant Gastric Cancer". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT02792881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*